J Urol. 2003 Jul;170(1):313-4.

Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends.

Walsh PC.

Comment on

J Natl Cancer Inst. 2002 Jul 3;94(13):981-90.

PMID:: 14567302; [PubMed]

Publication Types

Comment

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

Related citations in PubMed

Estimating lead time and overdiagnosis associated with PSA screening from prostate cancer incidence trends. [Biometrics. 2008]
Estimating lead time and overdiagnosis associated with PSA screening from prostate cancer incidence trends.
Telesca D, Etzioni R, Gulati R. Biometrics. 2008 Mar; 64(1):10-9. Epub 2007 May 14.
Review Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC). [Can J Urol. 2005]
Review Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
Schröder FH. Can J Urol. 2005 Feb; 12 Suppl 1:2-6; discussion 92-3.
Prostate-specific antigen screening in a high-risk population: lessons from the community and how they relate to large-scale population-based studies. [Urology. 2005]
Prostate-specific antigen screening in a high-risk population: lessons from the community and how they relate to large-scale population-based studies.
Shelton JB, Barocas DA, Conway F, Hart K, Nelson K, Richstone L, Gonzalez RR, Raman JD, Scherr DS. Urology. 2005 May; 65(5):931-6.
Comparison of prostate-specific antigen and hormone levels among men in Singapore and the United States. [Cancer Epidemiol Biomarkers Pr...]
Comparison of prostate-specific antigen and hormone levels among men in Singapore and the United States.
Cheng I, Yu MC, Koh WP, Pike MC, Kolonel LN, Henderson BE, Stram DO. Cancer Epidemiol Biomarkers Prev. 2005 Jul; 14(7):1692-6.
Review Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force. [Ann Intern Med. 2008]
Review Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force.
Lin K, Lipsitz R, Miller T, Janakiraman S, U.S. Preventive Services Task Force. Ann Intern Med. 2008 Aug 5; 149(3):192-9.

See reviews... See all...

Recent activity

Clear Turn Off Turn On

Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. pros...
Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends.
J Urol. 2003 Jul ;170(1):313-4.

PubMed
[Functional consequences of cutaneous lipid perturbation].
[Functional consequences of cutaneous lipid perturbation].
Pathol Biol (Paris). 2003 Jul ;51(5):271-4.

PubMed
[French validation of the Verona Service Satisfaction Scale-VSSS-54F].
[French validation of the Verona Service Satisfaction Scale-VSSS-54F].
Encephale. 2003 Mar-Apr ;29(2):110-8.

PubMed
Results of surgical treatment of patients with Crohn's disease.
Results of surgical treatment of patients with Crohn's disease.
Ann Chir Gynaecol. 1992 ;81(3):277-83.

PubMed
Sexual function and the older woman.
Sexual function and the older woman.
Clin Geriatr Med. 2003 Aug ;19(3):463-72, v.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends.

Comment on

Publication Types

Publication Types

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

Related citations in PubMed

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information